APA (7th ed.) Citation

J, T., E, V. C., E, D., A, C., Y, H., T, A., . . . A, d. G. (2007). Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25(33), 5225. https://doi.org/10.1200/JCO.2007.13.2183

Chicago Style (17th ed.) Citation

J, Tabernero, et al. "Phase II Trial of Cetuximab in Combination with Fluorouracil, Leucovorin, and Oxaliplatin in the First-line Treatment of Metastatic Colorectal Cancer." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 25, no. 33 (2007): 5225. https://doi.org/10.1200/JCO.2007.13.2183.

MLA (9th ed.) Citation

J, Tabernero, et al. "Phase II Trial of Cetuximab in Combination with Fluorouracil, Leucovorin, and Oxaliplatin in the First-line Treatment of Metastatic Colorectal Cancer." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 25, no. 33, 2007, p. 5225, https://doi.org/10.1200/JCO.2007.13.2183.